Sun Pharma launches alopecia drug Leqselvi in US after settling patent dispute
Sun Pharma on Monday announced it has settled a patent row with American biopharma company Incyte Corporation over its hair-loss drug, paving the way for its launch in the US. The Mumbai-based drugmaker, embroiled in the lawsuit since last year, launched the specialty drug in the world’s largest pharmaceutical market on Monday. Leqselvi (oral deuruxolitinib) … Read more